Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PACRG antisense RNA 3 (PACRG-AS3) is a non-coding antisense long RNA gene located on chromosome 6 (chr6:163165414-163192002, hg38)[3][8]. It does not code for a protein but is thought to play roles in the regulation of its sense counterpart, the PACRG gene, which is involved in pathways relevant to neurodegeneration and immune response, though the precise biological functions and disease relevance of PACRG-AS3 itself remain uncharacterized[1][3][7][8]. No literature currently demonstrates PACRG-AS3 as a direct therapeutic target, nor are there reports of interacting drugs, mechanisms of drug action, or known safety concerns. Its main classification is as an antisense long noncoding RNA.
Not applicable; no known drugs or direct mechanism for clinical intervention
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PACRG antisense RNA 3 (PACRG-AS3).